Pro: Can biomarkers be gold standards in Alzheimer's disease?

Authors:
Sperling R; Johnson K.

Journal:
Alzheimers Res Ther

Publication Year: 2010

DOI:
10.1186/alzrt41

PMCID:
PMC2919697

PMID:
20587006

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Alzheimers Res Ther

Abbreviation: Alzheimers Res Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical …
Rezakhani S; Amiri M; Hassani A and 2 more (2024) - Transparency Score: 4/6
A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpress…
Jiang Z; Wang J; Qin Y and 17 more (2024) - Transparency Score: 3/6
A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers i…
van Dyck CH; Mecca AP; O'Dell RS and 8 more (2024) - Transparency Score: 4/6
Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer…
Li QY; Hu HY; Zhang GW and 8 more (2024) - Transparency Score: 3/6
Associations between genetically predicted plasma protein levels and Alzheimer's disease risk: a st…
Zhu J; Liu S; Walker KA and 10 more (2024) - Transparency Score: 5/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests KJ has served in the past as a consultant to GE HealthCare, who retains the commercial rights to PiB-PET amyloid imaging."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025